Alternative schedule ipilimumab plus nivolumab for first-line treatment of advanced kidney cancer
The combination of nivolumab with ipilimumab has been proven to [...]
The combination of nivolumab with ipilimumab has been proven to [...]
A recent study looked at the efficacy and safety of [...]
The standard of care recommended for the treatment of patients [...]
This presentation from the American Society of Clinical Oncology (ASCO) [...]
A recent study published in Science Direct followed patients with [...]
Tivozanib has been included as a first-line treatment recommendation for advanced renal [...]
Cabozantinib has been declined for a second time by the [...]
The following review of the literature for first-line treatment of [...]
The European Commission has approved the nivolumab plus ipilimumab combination [...]
This multicentre analysis of axitinib versus sunitinib used as first-line [...]